Inactief instrument

Andere talen Rain Oncology Inc.

Aandelen

RAIN

US75082Q1058

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Rain Oncology Acquisition by Pathos AI Completed	26/01
Pathos AI Completes Acquisition of Rain Oncology	26/01
Rain Oncology Inc.(NasdaqGS:RAIN) dropped from NASDAQ Composite Index	26/01
Rain Oncology Inc.(NasdaqGS:RAIN) dropped from S&P TMI Index	26/01
Pathos AI, Inc. completed the acquisition of Rain Oncology Inc. on January 26, 2024.	26/01
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN	05/01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL	04/01
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN	18/12
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos	14/12
Rain Oncology Agrees to be Acquired by Pathos AI	14/12
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders	14/12
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights	14/12
Rain Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	09/11
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences	16-10-23
Rain Oncology Insider Bought Shares Worth $279,030, According to a Recent SEC Filing	13-10-23
Concentra Biosciences, LLC submits a non-binding proposal to acquire Rain Oncology Inc. from Tang Capital Partners, LP, managed by Tang Capital Management, LLC and others for $45.5 million.	13-10-23
The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)	12-09-23
ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN	12-09-23
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)	11-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Rain Oncology Inc.

Aandelen

RAIN

US75082Q1058

Andere talen

Filters